Growth Metrics

Alnylam Pharmaceuticals (ALNY) EBIT Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28.05%
Dec 31, 2025 21.78%
Sep 30, 2025 29.44%
Jun 30, 2025 39.44%
Mar 31, 2025 15.84%
Dec 31, 2024 18.81%
Sep 30, 2024 18.68%
Jun 30, 2024 17.14%
Mar 31, 2024 25.46%
Dec 31, 2023 11.98%
Sep 30, 2023 23.22%
Jun 30, 2023 -3.62%
Mar 31, 2023 -0.32%
Dec 31, 2022 -5.07%
Sep 30, 2022 -15.45%
Jun 30, 2022 -9.73%
Mar 31, 2022 -6.62%
Dec 31, 2021 -11.01%
Sep 30, 2021 -11.24%
Jun 30, 2021 -9.59%
Mar 31, 2021 -11.10%
Dec 31, 2020 -15.99%
Sep 30, 2020 -23.52%
Jun 30, 2020 -22.21%
Mar 31, 2020 -32.11%
Dec 31, 2019 -45.50%
Sep 30, 2019 -36.77%
Jun 30, 2019 -39.33%
Mar 31, 2019 6.84%
Dec 31, 2018 -49.41%
Sep 30, 2018 -51.18%
Jun 30, 2018 -55.27%
Mar 31, 2018 -71.96%
Dec 31, 2017 -10.76%
Sep 30, 2017 -47.29%
Jun 30, 2017 -58.44%
Mar 31, 2017 -57.78%
Dec 31, 2016 -53.41%
Sep 30, 2016 -53.70%
Jun 30, 2016 -47.78%
Mar 31, 2016 -47.66%
Dec 31, 2015 -49.45%
Sep 30, 2015 -55.10%
Jun 30, 2015 -44.38%
Mar 31, 2015 -35.80%
Dec 31, 2014 -41.46%
Sep 30, 2014 -36.18%
Jun 30, 2014 -14.96%